Learn More
Medchemexpress LLC Gemcitabine monophosphate | 116371-67-6 | 99.98% | 343.18 | 10 MG

Supplier: Medchemexpress LLC HY1089321MG
Gemcitabine monophosphate is an active intermediate of Gemcitabine. It demonstrates a synergistic anti-cancer effect and can be delivered through nanoparticle formulation. It is intended for research use only.
- Active intermediate of Gemcitabine.
- Exhibits synergistic anti-cancer effects.
- Can be delivered via nanoparticles.
- Induces tumor cell apoptosis (30-40%).
- Reduces tumor cell proliferation (8 times).
- Significantly reduces tumor microvessel density (MVD).
- Inhibits tumor mitosis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.